Cardiovascular risk reduction over time in patients with diabetes or pre-diabetes undergoing bariatric surgery: data from a single-center retrospective observational study

Rubio-Almanza, Matilde; Cámara-Gómez, Rosa; Hervás‐Marín, David; Ponce-Marco, José Luis; Merino-Torres, Juan Francisco

doi:10.1186/s12902-018-0317-4

Cited by 21 publications

(23 citation statements)

References 27 publications

(23 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Improvement in glycaemic control and body weight in prediabetes and diabetic patients began at the first month postoperatively and persisted in the next 12 months. This result corresponded with the findings of Rubio-Almanza et al, who suggested that bariatric surgery improves glycaemic control and obesity comorbidities in prediabetes patients [ 22 ]. In addition, nearly 70% of prediabetes cases in our centre were treated by LSG.…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

Bile acid, glucose, lipid profile, and liver enzyme changes in prediabetic patients 1 year after sleeve gastrectomy

et al. 2020

View full text Add to dashboard Cite

Background Few articles have studied individuals with prediabetes after sleeve gastrectomy. Bile acid and lipid levels remain inconsistent in postbariatric patients. The purpose of this study was to explore bile acid, glucose, lipid, and liver enzyme changes in patients with different diabetes statuses who underwent sleeve gastrectomy. The impact of bariatric surgery and its potential benefits for prediabetic patients was also discussed. Methods A total of 202 overweight and obese patients who underwent bariatric surgery in our hospital between January 2016 and October 2018 were retrospectively reviewed. Patients were divided into prediabetes (n = 32), nondiabetes (n = 144), and diabetes (n = 26) groups and analysed. Glucose and lipid data were collected from medical records at baseline and at each follow-up visit. Result Significant improvements in body weight, glucose and lipid levels, and liver enzymes (P ≤ 0.05) in prediabetic patients were found throughout the first year postoperatively. Improvement in glycaemic control was first seen one month postoperatively, followed by persistent improvement in the next 12 months. Total bile acid (TBA) decreased, which was associated with ALT improvement in prediabetic patients 1-year post-surgery. There were no significant differences in HbA1c, glucose, or triglycerides (TGs) between prediabetic and T2DM patients or between prediabetic and nondiabetic patients at 12 months post-surgery. Conclusion LSG is highly effective at interfering with glucose and lipid levels as well as total bile acid levels in prediabetic patients in the first year postoperatively. Thus, LSG is indeed an alternative for overweight and obese prediabetic patients.

show abstract

Section: Discussionsupporting

confidence: 91%

“…that bariatric surgery improves glycaemic control and obesity comorbidities in prediabetes patients [22]. In addition, nearly 70% of prediabetes cases in our centre were treated by LSG.…”

Section: Ast (U/l)mentioning

confidence: 77%

Bile acid, glucose, lipid profile, and liver enzyme changes in prediabetic patients 1 year after sleeve gastrectomy

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Improvement in glycaemic control and body weight in prediabetes and diabetic patients began at the rst month postoperatively and persisted in the next 12 months. This result corresponded with the ndings of Rubio-Almanza et al, who suggested that bariatric surgery improves glycaemic control and obesity comorbidities in prediabetes patients [22]. In addition, nearly 70% of prediabetes cases in our centre were treated by LSG.…”

Section: Discussionsupporting

confidence: 90%

Bile acid, glucose, lipid profile, and liver enzyme changes in prediabetic patients 1 year after sleeve gastrectomy

Mak

Huang

Guan

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Few articles have studied individuals with prediabetes after sleeve gastrectomy. Bile acid and lipid levels remain inconsistent in postbariatric patients. The purpose of this study was to explore bile acid, glucose, lipid, and liver enzyme changes in patients with different diabetes statuses who underwent sleeve gastrectomy. The impact of bariatric surgery and its potential benefits for prediabetic patients was also discussed.Methods: A total of 202 overweight and obese patients who underwent bariatric surgery in our hospital between January 2016 and October 2018 were retrospectively reviewed. Patients were divided into prediabetes (n=32), nondiabetes (n=144), and diabetes (n=26) groups and analysed. Glucose and lipid data were collected from medical records at baseline and at each follow-up visit.Result: Significant improvements in body weight, glucose and lipid levels, and liver enzymes (P≤0.05) in prediabetic patients were found throughout the first year postoperatively. Improvement in glycaemic control was first seen one month postoperatively, followed by persistent improvement in the next 12 months. Total bile acid (TBA) decreased, which was associated with ALT improvement in prediabetic patients 1-year post-surgery. There were no significant differences in HbA1c, glucose, or triglycerides (TGs) between prediabetic and T2DM patients or between prediabetic and nondiabetic patients at 12 months post-surgery.Conclusion: LSG is highly effective at interfering with glucose and lipid levels as well as total bile acid levels in prediabetic patients in the first year postoperatively. Thus, LSG is indeed an alternative for overweight and obese prediabetic patients.

show abstract

“…Improvement of glycemic control and body weight in pre-diabetics and diabetics began at the rst month post-op and persisted in the next 12 months. This corresponded to Rubio-Almanza et al, who suggested that bariatric surgery improved glycemic control and obesity comorbidities in the pre-diabetes patient [22]. Besides, nearly 70% of pre-diabetics in our centre was treated by LSG.…”

Section: Discussionsupporting

confidence: 81%

Bile acid, glucose, lipid profile, and liver enzyme changes in pre-diabetics after sleeve gastrectomy

Mak

Huang

Guan

et al. 2020

Preprint

View full text Add to dashboard Cite

BackgroundFew articles have studied pre-diabetes after sleeve gastrectomy. Bile acid, and lipid metabolism remains inconsistent in post-bariatric patients. ObjectiveTo explore bile acid and glucose, lipid, and liver enzyme changes in different diabetic status underwent sleeve gastrectomy. To discuss the impact of bariatric surgery and its potential benefits to pre-diabeticsMethods202 overweight and obese patients underwent bariatric surgery between January 2016 and October 2018 in our hospital were retrospectively reviewed. They were divided into Pre-diabetes (n=32), Non-diabetes (n=144), and Diabetes (n=26) and analyzed respectively. Data of glucose and lipid metabolism were collected from medical records from baseline and each follow-up visit.ResultSignificant improvement in body weight, glucose and lipid metabolism, and liver enzyme at P≤0.05 in prediabetics were found throughout first year post-op. Improvement of glycemic control was first seen in a month post op, followed by persistent improvement in the next 12 months. Total bile acid (TBA) decreased, associated with ALT improvement, in pre-diabetes 1-year post-surgery. There was no significant differences in HbA1c, glucose, and triglycerides (TG) between Pre-diabetics and T2DM nor between prediabetics and non-diabetics at 12 months post-surgery.ConclusionLSG is highly effective in interfering glucose and lipid metabolism as well as total bile acid of prediabetics in the first year post op. Thus, LSG is indeed an alternative for overweight and obese prediabetics

show abstract

Cardiovascular risk reduction over time in patients with diabetes or pre-diabetes undergoing bariatric surgery: data from a single-center retrospective observational study

Cited by 21 publications

References 27 publications

Bile acid, glucose, lipid profile, and liver enzyme changes in prediabetic patients 1 year after sleeve gastrectomy

Bile acid, glucose, lipid profile, and liver enzyme changes in prediabetic patients 1 year after sleeve gastrectomy

Bile acid, glucose, lipid profile, and liver enzyme changes in prediabetic patients 1 year after sleeve gastrectomy

Bile acid, glucose, lipid profile, and liver enzyme changes in pre-diabetics after sleeve gastrectomy

Contact Info

Product

Resources

About